 December
11, 2006 (FinancialWire) MIV Therapeutics Inc (OTCBB: MIVT) gained 18%
Friday on volume of 408,585, which was more than twice its three-month
average 168,178, to end the day at $0.59.
December 11, 2006
(FinancialWire) MIV Therapeutics Inc (OTCBB: MIVT) gained 18% Friday on
volume of 408,585, which was more than twice its three-month average
168,178, to end the day at $0.59.
Companies in the sector
include Medtronic Inc. (NYSE: MDT), Boston Scientific Corp. (NYSE:
BSX), and Johnson & Johnson (NYSE: JNJ).
MIV Therapeutics
was enrolled in Investrend Research affiliate SISM Research's
professional analyst program. Complete information is available at the
company's InvestorPower page, which is accessible from http://www.investrend.com/company/list.asp?sPathParam=yes .
For up-to-the-minute news, features and links click on http://www.FinancialWire.net
FinancialWire
is an independent, proprietary news service of Investrend Information,
a division of Investrend Communications, Inc. It is not a press release
service and receives no compensation from any company for its news or
opinions. Other divisions of Investrend, however, provide shareholder
empowerment platforms such as forums, independent research and
webcasting. For more information or to receive the FirstAlert daily
summary of news, commentary, research reports, webcasts, events and
conference calls, click on http://www.investrend.com/contact.asp
For a free annual report on a company mentioned in the news, please click on http://investrend.ar.wilink.com/?level=279
To
become an investor monitor of independent research for a company in
which you are invested, go to the not-for-profit Shareholders Research
Alliance, Inc. website by clicking on http://www.shareholdersresearch.com/
The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www.investrend.com/XmlFeeds?level=268
PRINT THIS PAGE | SEND IT TO A FRIEND | | | |
|
|